Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019

• Autori principali: Matthäus Lottes (Autore), Viviane Bremer (Autore), Christof Prugger (Autore), Christian Kollan (Autore), Daniel Schmidt (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2022-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Recent patent losses for antiretroviral drugs (ARV) have led to the debate of cost-saving through the replacement of patented drugs with generic drugs. The split of recommended single-tablet regimens (STR) into their single substance partners is one of the considerations mentione...